Breast Biopsy Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2032

Description

Persistence Market Research has recently released a comprehensive report on the worldwide market for breast biopsy. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global breast biopsy market from 2025 to 2032.

Key Insights: Breast Biopsy Market

Breast Biopsy Market Size (2025E): US$ 2,465.9 Million
Projected Market Value (2032F): US$ 3,587.1 Million
Global Market Growth Rate (CAGR 2025 to 2032): 5.5%

Breast Biopsy Market - Report Scope:

Breast biopsy is a critical diagnostic procedure used to evaluate suspicious breast abnormalities and confirm the presence of cancer or benign conditions. The procedure involves the removal of tissue or fluid samples from the breast for histopathological examination. The breast biopsy market caters to hospitals, specialty clinics, ambulatory surgical centers, and cancer research institutes, offering a wide range of products including biopsy needles, vacuum-assisted devices, imaging-guided biopsy systems, localization wires, and biopsy markers.

The increasing global prevalence of breast cancer, growing awareness regarding early diagnosis, and advancements in imaging technologies such as ultrasound, MRI, and 3D mammography are key contributors to market growth. Additionally, the shift toward minimally invasive biopsy procedures and image-guided techniques has significantly improved diagnostic accuracy and patient outcomes, further accelerating market expansion.

Market Growth Drivers:

The global breast biopsy market is propelled by several key factors, including the rising incidence of breast cancer worldwide and increasing participation in screening programs. Growing public health initiatives promoting early detection and advancements in diagnostic imaging technologies are significantly enhancing the adoption of biopsy procedures.

Technological innovations such as vacuum-assisted biopsy (VAB) systems, MRI-guided biopsy platforms, and real-time ultrasound-guided procedures have improved precision, reduced procedural time, and minimized patient discomfort. The integration of artificial intelligence in imaging systems is also supporting radiologists in identifying suspicious lesions more accurately.

Furthermore, the growing preference for minimally invasive procedures over open surgical biopsies, combined with shorter recovery times and reduced hospitalization costs, is fostering demand. Expanding healthcare infrastructure in emerging economies and increasing healthcare expenditure further contribute to sustained market growth.

Market Restraints:

Despite favorable growth prospects, the breast biopsy market faces certain challenges. High costs associated with advanced imaging-guided biopsy systems and vacuum-assisted devices may limit adoption in low- and middle-income countries. Reimbursement limitations in certain regions and stringent regulatory requirements for medical devices can also impact market expansion.

Additionally, procedural complications such as bleeding, infection, and patient anxiety related to biopsy procedures may deter some patients from undergoing timely diagnosis. Limited access to skilled healthcare professionals in remote and underserved areas further restricts widespread adoption of advanced biopsy techniques.

Addressing these challenges requires enhanced reimbursement frameworks, improved training programs for healthcare professionals, and the development of cost-effective biopsy solutions to ensure broader accessibility.

Market Opportunities:

The breast biopsy market presents significant growth opportunities driven by technological advancements and increasing emphasis on personalized medicine. The development of robotic-assisted biopsy systems, AI-powered imaging platforms, and portable biopsy devices is expected to enhance diagnostic precision and workflow efficiency.

Emerging markets in South Asia, East Asia, Latin America, and the Middle East & Africa offer substantial untapped potential due to rising awareness, expanding screening initiatives, and improving healthcare infrastructure. Strategic collaborations between medical device manufacturers and healthcare providers are likely to improve access to advanced diagnostic tools.

Moreover, growing investments in cancer research, biomarker discovery, and precision oncology are expected to increase demand for high-quality tissue sampling and advanced biopsy markers, supporting long-term market growth.

Key Questions Answered in the Report:

What are the primary factors driving the growth of the global breast biopsy market?
Which product segments and indications are contributing most significantly to market expansion?
How are technological advancements reshaping the competitive landscape of the breast biopsy market?
Who are the key players contributing to the breast biopsy market, and what strategies are they employing to maintain market relevance?
What are the emerging trends and future prospects in the global breast biopsy market?

Competitive Intelligence and Business Strategy:

Leading players in the global breast biopsy market, including Argon Medical, Becton Dickinson and Company, C.R. Bard, Inc., Cook Medical Inc., Devicor Medical Products, Inc., F. Hoffmann-La Roche Ltd., GE Healthcare, Hologic, Inc., Leica Biosystems, Medax Srl Unipersonale, Planmed Oy, Scion Medical Technologies, LLC, Siemens Healthineers, Hikma Pharmaceuticals, and Incytes, focus on product innovation, strategic acquisitions, and geographic expansion to strengthen their market position.

These companies invest heavily in research and development to introduce advanced biopsy needles, imaging-guided systems, and vacuum-assisted technologies. Partnerships with hospitals, cancer centers, and research institutes enable clinical validation and improved product adoption. Additionally, expanding distribution networks and focusing on regulatory approvals in emerging markets remain key strategic priorities for sustaining competitive advantage.

Key Companies Profiled:

Argon Medical
Becton Dickinson and Company
C.R. Bard, Inc.
Cook Medical Inc.
Devicor Medical Products, Inc.
F. Hoffmann-La Roche Ltd.
GE Healthcare
Hologic, Inc.
Leica Biosystems
Medax Srl Unipersonale
Planmed Oy
Scion Medical Technologies, LLC
Siemens Healthineers
Hikma Pharmaceuticals
Incytes

Breast Biopsy Market Research Segmentation:

By Product:

Biopsy Needles
Core Needles
Fine Aspiration Needles
MRI-Guide Biopsy Systems
Ultrasound Guided Breast Biopsy Systems
Two-Dimensional (2D) Mammographic Ultrasonic Scanning Systems
Three-Dimensional (3D) B-Mode Mammographic Ultrasonic Scanning Systems
Vacuum-Assisted Devices (VAD)
Guide Wire (Localization Wire)
Breast Biopsy Markers

By Indication:

Complex Cysts
Solid Mass
Suspicious Solid Mass (Fibroadenoma)
Suspicious Micro-calcifications

By End User:

Hospitals
Specialty Clinics
Ambulatory Surgical Centers
Cancer Research Institutes

By Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa (MEA)

Product Code: PMRREP33464

1. Executive Summary

1.1. Global Breast Biopsy Market Snapshot 2025 and 2032
1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
1.3. Key Market Trends
1.4. Industry Developments and Key Market Events
1.5. Demand Side and Supply Side Analysis
1.6. PMR Analysis and Recommendations

2. Market Overview

2.1. Market Scope and Definitions
2.2. Value Chain Analysis
2.3. Macro-Economic Factors
- 2.3.1. Global GDP Outlook
- 2.3.2. Global GDP Outlook
- 2.3.3. Global economic Growth Forecast
- 2.3.4. Global Urbanization Growth
- 2.3.5. Other Macro-economic Factors
2.4. Forecast Factors - Relevance and Impact
2.5. COVID-19 Impact Assessment
2.6. PESTLE Analysis
2.7. Porter's Five Forces Analysis
2.8. Geopolitical Tensions: Market Impact
2.9. Regulatory and Technology Landscape

3. Market Dynamics

3.1. Drivers
3.2. Restraints
3.3. Opportunities
3.4. Trends

4. Price Trend Analysis, 2019 - 2032

4.1. Region-wise Price Analysis
4.2. Price by Segments
4.3. Price Impact Factors

5. Global Breast Biopsy Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

5.1. Key Highlights
5.2. Global Breast Biopsy Market Outlook: Product
- 5.2.1. Introduction/Key Findings
- 5.2.2. Historical Market Size (US$ Mn) Analysis by Product, 2019-2024
- 5.2.3. Current Market Size (US$ Mn) Forecast, by Product, 2025-2032
  - 5.2.3.1. Biopsy Needles
    - 5.2.3.1.1. Core Needles
    - 5.2.3.1.2. Fine Aspiration Needles
  - 5.2.3.2. MRI-Guide Biopsy Systems
  - 5.2.3.3. Ultrasound Guided Breast Biopsy Systems
    - 5.2.3.3.1. Two-Dimensional (2D) Mammographic Ultrasonic Scanning Systems
    - 5.2.3.3.2. Three-Dimensional (3D) B-Mode Mammographic Ultrasonic Scanning Systems
  - 5.2.3.4. Vacuum-Assisted Devices (VAD)
  - 5.2.3.5. Guide Wire (Localization Wire)
  - 5.2.3.6. Breast Biopsy Markers
- 5.2.4. Market Attractiveness Analysis: Product
5.3. Global Breast Biopsy Market Outlook: Indication
- 5.3.1. Introduction/Key Findings
- 5.3.2. Historical Market Size (US$ Mn) Analysis by Indication, 2019-2024
- 5.3.3. Current Market Size (US$ Mn) Forecast, by Indication, 2025-2032
  - 5.3.3.1. Complex Cysts
  - 5.3.3.2. Solid Mass
  - 5.3.3.3. Suspicious Solid Mass (Fibroadenoma)
  - 5.3.3.4. Suspicious Micro-calcifications
- 5.3.4. Market Attractiveness Analysis: Indication
5.4. Global Breast Biopsy Market Outlook: End User
- 5.4.1. Introduction/Key Findings
- 5.4.2. Historical Market Size (US$ Mn) Analysis by End User, 2019-2024
- 5.4.3. Current Market Size (US$ Mn) Forecast, by End User, 2025-2032
  - 5.4.3.1. Hospitals
  - 5.4.3.2. Specialty Clinics
  - 5.4.3.3. Ambulatory Surgical Centers
  - 5.4.3.4. Cancer Research Institutes
- 5.4.4. Market Attractiveness Analysis: End User

6. Global Breast Biopsy Market Outlook: Region

6.1. Key Highlights
6.2. Historical Market Size (US$ Mn) Analysis by Region, 2019-2024
6.3. Current Market Size (US$ Mn) Forecast, by Region, 2025-2032
- 6.3.1. North America
- 6.3.2. Europe
- 6.3.3. East Asia
- 6.3.4. South Asia & Oceania
- 6.3.5. Latin America
- 6.3.6. Middle East & Africa
6.4. Market Attractiveness Analysis: Region

7. North America Breast Biopsy Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

7.1. Key Highlights
7.2. Pricing Analysis
7.3. North America Market Size (US$ Mn) Forecast, by Country, 2025-2032
- 7.3.1. U.S.
- 7.3.2. Canada
7.4. North America Market Size (US$ Mn) Forecast, by Product, 2025-2032
- 7.4.1. Biopsy Needles
  - 7.4.1.1. Core Needles
  - 7.4.1.2. Fine Aspiration Needles
- 7.4.2. MRI-Guide Biopsy Systems
- 7.4.3. Ultrasound Guided Breast Biopsy Systems
  - 7.4.3.1. Two-Dimensional (2D) Mammographic Ultrasonic Scanning Systems
  - 7.4.3.2. Three-Dimensional (3D) B-Mode Mammographic Ultrasonic Scanning Systems
- 7.4.4. Vacuum-Assisted Devices (VAD)
- 7.4.5. Guide Wire (Localization Wire)
- 7.4.6. Breast Biopsy Markers
7.5. North America Market Size (US$ Mn) Forecast, by Indication, 2025-2032
- 7.5.1. Complex Cysts
- 7.5.2. Solid Mass
- 7.5.3. Suspicious Solid Mass (Fibroadenoma)
- 7.5.4. Suspicious Micro-calcifications
7.6. North America Market Size (US$ Mn) Forecast, by End User, 2025-2032
- 7.6.1. Hospitals
- 7.6.2. Specialty Clinics
- 7.6.3. Ambulatory Surgical Centers
- 7.6.4. Cancer Research Institutes

8. Europe Breast Biopsy Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

8.1. Key Highlights
8.2. Pricing Analysis
8.3. Europe Market Size (US$ Mn) Forecast, by Country, 2025-2032
- 8.3.1. Germany
- 8.3.2. Italy
- 8.3.3. France
- 8.3.4. U.K.
- 8.3.5. Spain
- 8.3.6. Russia
- 8.3.7. Rest of Europe
8.4. Europe Market Size (US$ Mn) Forecast, by Product, 2025-2032
- 8.4.1. Biopsy Needles
  - 8.4.1.1. Core Needles
  - 8.4.1.2. Fine Aspiration Needles
- 8.4.2. MRI-Guide Biopsy Systems
- 8.4.3. Ultrasound Guided Breast Biopsy Systems
  - 8.4.3.1. Two-Dimensional (2D) Mammographic Ultrasonic Scanning Systems
  - 8.4.3.2. Three-Dimensional (3D) B-Mode Mammographic Ultrasonic Scanning Systems
- 8.4.4. Vacuum-Assisted Devices (VAD)
- 8.4.5. Guide Wire (Localization Wire)
- 8.4.6. Breast Biopsy Markers
8.5. Europe Market Size (US$ Mn) Forecast, by Indication, 2025-2032
- 8.5.1. Complex Cysts
- 8.5.2. Solid Mass
- 8.5.3. Suspicious Solid Mass (Fibroadenoma)
- 8.5.4. Suspicious Micro-calcifications
8.6. Europe Market Size (US$ Mn) Forecast, by End User, 2025-2032
- 8.6.1. Hospitals
- 8.6.2. Specialty Clinics
- 8.6.3. Ambulatory Surgical Centers
- 8.6.4. Cancer Research Institutes

9. East Asia Breast Biopsy Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

9.1. Key Highlights
9.2. Pricing Analysis
9.3. East Asia Market Size (US$ Mn) Forecast, by Country, 2025-2032
- 9.3.1. China
- 9.3.2. Japan
- 9.3.3. South Korea
9.4. East Asia Market Size (US$ Mn) Forecast, by Product, 2025-2032
- 9.4.1. Biopsy Needles
  - 9.4.1.1. Core Needles
  - 9.4.1.2. Fine Aspiration Needles
- 9.4.2. MRI-Guide Biopsy Systems
- 9.4.3. Ultrasound Guided Breast Biopsy Systems
  - 9.4.3.1. Two-Dimensional (2D) Mammographic Ultrasonic Scanning Systems
  - 9.4.3.2. Three-Dimensional (3D) B-Mode Mammographic Ultrasonic Scanning Systems
- 9.4.4. Vacuum-Assisted Devices (VAD)
- 9.4.5. Guide Wire (Localization Wire)
- 9.4.6. Breast Biopsy Markers
9.5. East Asia Market Size (US$ Mn) Forecast, by Indication, 2025-2032
- 9.5.1. Complex Cysts
- 9.5.2. Solid Mass
- 9.5.3. Suspicious Solid Mass (Fibroadenoma)
- 9.5.4. Suspicious Micro-calcifications
9.6. East Asia Market Size (US$ Mn) Forecast, by End User, 2025-2032
- 9.6.1. Hospitals
- 9.6.2. Specialty Clinics
- 9.6.3. Ambulatory Surgical Centers
- 9.6.4. Cancer Research Institutes

10. South Asia & Oceania Breast Biopsy Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

10.1. Key Highlights
10.2. Pricing Analysis
10.3. South Asia & Oceania Market Size (US$ Mn) Forecast, by Country, 2025-2032
- 10.3.1. India
- 10.3.2. Southeast Asia
- 10.3.3. ANZ
- 10.3.4. Rest of SAO
10.4. South Asia & Oceania Market Size (US$ Mn) Forecast, by Product, 2025-2032
- 10.4.1. Biopsy Needles
  - 10.4.1.1. Core Needles
  - 10.4.1.2. Fine Aspiration Needles
- 10.4.2. MRI-Guide Biopsy Systems
- 10.4.3. Ultrasound Guided Breast Biopsy Systems
  - 10.4.3.1. Two-Dimensional (2D) Mammographic Ultrasonic Scanning Systems
  - 10.4.3.2. Three-Dimensional (3D) B-Mode Mammographic Ultrasonic Scanning Systems
- 10.4.4. Vacuum-Assisted Devices (VAD)
- 10.4.5. Guide Wire (Localization Wire)
- 10.4.6. Breast Biopsy Markers
10.5. South Asia & Oceania Market Size (US$ Mn) Forecast, by Indication, 2025-2032
- 10.5.1. Complex Cysts
- 10.5.2. Solid Mass
- 10.5.3. Suspicious Solid Mass (Fibroadenoma)
- 10.5.4. Suspicious Micro-calcifications
10.6. South Asia & Oceania Market Size (US$ Mn) Forecast, by End User, 2025-2032
- 10.6.1. Hospitals
- 10.6.2. Specialty Clinics
- 10.6.3. Ambulatory Surgical Centers
- 10.6.4. Cancer Research Institutes

11. Latin America Breast Biopsy Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

11.1. Key Highlights
11.2. Pricing Analysis
11.3. Latin America Market Size (US$ Mn) Forecast, by Country, 2025-2032
- 11.3.1. Brazil
- 11.3.2. Mexico
- 11.3.3. Rest of LATAM
11.4. Latin America Market Size (US$ Mn) Forecast, by Product, 2025-2032
- 11.4.1. Biopsy Needles
  - 11.4.1.1. Core Needles
  - 11.4.1.2. Fine Aspiration Needles
- 11.4.2. MRI-Guide Biopsy Systems
- 11.4.3. Ultrasound Guided Breast Biopsy Systems
  - 11.4.3.1. Two-Dimensional (2D) Mammographic Ultrasonic Scanning Systems
  - 11.4.3.2. Three-Dimensional (3D) B-Mode Mammographic Ultrasonic Scanning Systems
- 11.4.4. Vacuum-Assisted Devices (VAD)
- 11.4.5. Guide Wire (Localization Wire)
- 11.4.6. Breast Biopsy Markers
11.5. Latin America Market Size (US$ Mn) Forecast, by Indication, 2025-2032
- 11.5.1. Complex Cysts
- 11.5.2. Solid Mass
- 11.5.3. Suspicious Solid Mass (Fibroadenoma)
- 11.5.4. Suspicious Micro-calcifications
11.6. Latin America Market Size (US$ Mn) Forecast, by End User, 2025-2032
- 11.6.1. Hospitals
- 11.6.2. Specialty Clinics
- 11.6.3. Ambulatory Surgical Centers
- 11.6.4. Cancer Research Institutes

12. Middle East & Africa Breast Biopsy Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

12.1. Key Highlights
12.2. Pricing Analysis
12.3. Middle East & Africa Market Size (US$ Mn) Forecast, by Country, 2025-2032
- 12.3.1. GCC Countries
- 12.3.2. South Africa
- 12.3.3. Northern Africa
- 12.3.4. Rest of MEA
12.4. Middle East & Africa Market Size (US$ Mn) Forecast, by Product, 2025-2032
- 12.4.1. Biopsy Needles
  - 12.4.1.1. Core Needles
  - 12.4.1.2. Fine Aspiration Needles
- 12.4.2. MRI-Guide Biopsy Systems
- 12.4.3. Ultrasound Guided Breast Biopsy Systems
  - 12.4.3.1. Two-Dimensional (2D) Mammographic Ultrasonic Scanning Systems
  - 12.4.3.2. Three-Dimensional (3D) B-Mode Mammographic Ultrasonic Scanning Systems
- 12.4.4. Vacuum-Assisted Devices (VAD)
- 12.4.5. Guide Wire (Localization Wire)
- 12.4.6. Breast Biopsy Markers
12.5. Middle East & Africa Market Size (US$ Mn) Forecast, by Indication, 2025-2032
- 12.5.1. Complex Cysts
- 12.5.2. Solid Mass
- 12.5.3. Suspicious Solid Mass (Fibroadenoma)
- 12.5.4. Suspicious Micro-calcifications
12.6. Middle East & Africa Market Size (US$ Mn) Forecast, by End User, 2025-2032
- 12.6.1. Hospitals
- 12.6.2. Specialty Clinics
- 12.6.3. Ambulatory Surgical Centers
- 12.6.4. Cancer Research Institutes

13. Competition Landscape

13.1. Market Share Analysis, 2024
13.2. Market Structure
- 13.2.1. Competition Intensity Mapping
- 13.2.2. Competition Dashboard
13.3. Company Profiles
- 13.3.1. Argon Medical
  - 13.3.1.1. Company Overview
  - 13.3.1.2. Product Portfolio/Offerings
  - 13.3.1.3. Key Financials
  - 13.3.1.4. SWOT Analysis
  - 13.3.1.5. Company Strategy and Key Developments
- 13.3.2. Becton Dickinson and Company
- 13.3.3. C.R. Bard, Inc.
- 13.3.4. Cook Medical Inc.
- 13.3.5. Devicor Medical Products, Inc.
- 13.3.6. F. Hoffmann-La Roche Ltd.,
- 13.3.7. GE Healthcare
- 13.3.8. Hologic, Inc.
- 13.3.9. Leica Biosystems
- 13.3.10. Medax Srl Unipersonale
- 13.3.11. Planmed Oy
- 13.3.12. Scion Medical Technologies, LLC
- 13.3.13. Siemens Healthineers
- 13.3.14. Hikma Pharmaceuticals
- 13.3.15. Incytes

14. Appendix

14.1. Research Methodology
14.2. Research Assumptions
14.3. Acronyms and Abbreviations